ATE71843T1 - Behandlung des atemunwohlseinsyndroms bei erwachsenen. - Google Patents

Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Info

Publication number
ATE71843T1
ATE71843T1 AT86902635T AT86902635T ATE71843T1 AT E71843 T1 ATE71843 T1 AT E71843T1 AT 86902635 T AT86902635 T AT 86902635T AT 86902635 T AT86902635 T AT 86902635T AT E71843 T1 ATE71843 T1 AT E71843T1
Authority
AT
Austria
Prior art keywords
syndrome
wellbeing
adults
respiratory
treatment
Prior art date
Application number
AT86902635T
Other languages
English (en)
Inventor
Thomas A Raffin
John H Stevens
Original Assignee
Thomas A Raffin
John H Stevens
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas A Raffin, John H Stevens filed Critical Thomas A Raffin
Application granted granted Critical
Publication of ATE71843T1 publication Critical patent/ATE71843T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
AT86902635T 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen. ATE71843T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/718,918 US4686100A (en) 1985-04-02 1985-04-02 Method for the treatment of adult respiratory distress syndrome
EP86902635A EP0219524B1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen
PCT/US1986/000659 WO1986005692A2 (en) 1985-04-02 1986-03-31 Treatment of adult respiratory distress syndrome

Publications (1)

Publication Number Publication Date
ATE71843T1 true ATE71843T1 (de) 1992-02-15

Family

ID=24888089

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86902635T ATE71843T1 (de) 1985-04-02 1986-03-31 Behandlung des atemunwohlseinsyndroms bei erwachsenen.

Country Status (6)

Country Link
US (1) US4686100A (de)
EP (1) EP0219524B1 (de)
JP (1) JPS62502616A (de)
AT (1) ATE71843T1 (de)
DE (1) DE3683586D1 (de)
WO (1) WO1986005692A2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5147637A (en) * 1988-06-07 1992-09-15 The Rockefeller University Method of inhibiting the influx of leukocytes into organs during sepsis or other trauma
US4966137A (en) * 1989-09-19 1990-10-30 Davini Mark A Splint system
US5322699A (en) * 1991-02-04 1994-06-21 The Rockefeller University Leukocyte-derived CR3 modulator, integrin modulating factor-1 (IMF-1)
EP0523856A3 (en) * 1991-06-28 1993-03-17 Sgs-Thomson Microelectronics, Inc. Method of via formation for multilevel interconnect integrated circuits
WO1993011784A1 (en) * 1991-12-13 1993-06-24 Duke University Methods for inhibition or stimulation of the inflammatory response
US5837499A (en) * 1993-12-06 1998-11-17 Ciba-Geigy Corporation DNA encoding C5A receptor antagonists having substantially no agonist activity and methods of expressing same
US5807824A (en) * 1993-12-06 1998-09-15 Ciba-Geigy Corporation C5A receptor antagonists having substantially no agonist activity
AU2191795A (en) * 1994-03-23 1995-10-09 Alexion Pharmaceuticals, Inc. Method for reducing immune and hemostatic dysfunctions during extracorporeal circulation
US5504090A (en) * 1994-03-30 1996-04-02 Trustees Of The University Of Pennsylvania Compositions and methods for the prevention and treatment of ischemia-reperfusion organ injury
US6074642A (en) 1994-05-02 2000-06-13 Alexion Pharmaceuticals, Inc. Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
US5504111A (en) * 1994-12-30 1996-04-02 Medichem Research, Inc. Use of 2,3 alkylcarbonyloxybenzoic acid in treating adult respiratory distress syndrome
JP2000506170A (ja) * 1996-03-05 2000-05-23 メデイノックス，インコーポレイテッド 酸化窒素スキャベンジャーを用いる複合治療方法とそのために有用な組成物
US6673346B1 (en) * 1999-08-31 2004-01-06 The Regents Of The University Of Michigan Compositions and methods for the treatment of sepsis
WO2003015819A1 (en) * 2001-08-17 2003-02-27 Tanox, Inc. Complement pathway inhibitors binding to c5 and c5a without preventing formation of c5b
EP3372243A1 (de) 2001-08-17 2018-09-12 Genentech, Inc. Komplement-inhibitoren, die an c5 und c5a binden, ohne die bildung von c5b zu hemmen
JP4601426B2 (ja) 2002-09-06 2010-12-22 アレクシオン ファーマシューティカルズ， インコーポレイテッド 補体成分ｃ５に対する抗体を使用する喘息の処置の方法
US20070116710A1 (en) * 2004-02-03 2007-05-24 Leonard Bell Methods of treating hemolytic anemia
US20050169921A1 (en) 2004-02-03 2005-08-04 Leonard Bell Method of treating hemolytic disease
US20070196367A1 (en) * 2006-02-22 2007-08-23 Valentin Dinu Methods of preventing and treating Alzheimer's disease, age related macular degeneration and other diseases involving extra-cellular debris through the inhibition of the complement system
PL3167888T3 (pl) 2006-03-15 2024-08-26 Alexion Pharmaceuticals, Inc. Leczenie pacjentów z napadową nocną hemoglobinurią za pomocą inhibitora dopełniacza
HUE061548T2 (hu) 2008-11-10 2023-07-28 Alexion Pharma Inc Komplementtel összefüggõ rendellenességek kezelésére szolgáló eljárások és készítmények
TWI465434B (zh) 2008-12-22 2014-12-21 Chemocentryx Inc Ｃ５ａＲ拮抗劑
AU2011245117B2 (en) 2010-04-30 2015-03-12 Alexion Pharmaceuticals, Inc. Anti-C5a antibodies and methods for using the antibodies
US9126939B2 (en) 2010-06-24 2015-09-08 Pingchen Fan C5AR antagonists
EP2468295A1 (de) 2010-12-21 2012-06-27 Affiris AG Impfstoffe basierend auf Komplementprotein C5a Peptide
KR102192596B1 (ko) 2013-08-07 2020-12-18 알렉시온 파마슈티칼스, 인코포레이티드 비정형적 용혈성 요독증후군 (ahus) 바이오마커 단백질
CN106999481B (zh) 2014-09-29 2021-04-16 凯莫森特里克斯股份有限公司 制备C5aR拮抗剂的方法和中间体
KR102767008B1 (ko) 2016-01-14 2025-02-11 케모센트릭스, 인크. C3 사구체병증을 치료하는 방법
AU2017283470B2 (en) 2016-06-14 2024-03-21 Regeneron Pharmaceuticals, Inc. Anti-C5 antibodies and uses thereof
WO2019118556A1 (en) 2017-12-13 2019-06-20 Regeneron Pharmaceuticals, Inc. Anti-c5 antibody combinations and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3407M (fr) * 1964-03-25 1965-07-05 Michel Plissier Immunoglobulines anti-antigenes microbiens et viraux, seules ou associées, utilisées dans la prévention et le traitement des syndromes infectieux respiratoires.

Also Published As

Publication number Publication date
US4686100A (en) 1987-08-11
EP0219524B1 (de) 1992-01-22
DE3683586D1 (de) 1992-03-05
WO1986005692A2 (en) 1986-10-09
JPS62502616A (ja) 1987-10-08
EP0219524A1 (de) 1987-04-29

Similar Documents

Publication Publication Date Title
ATE71843T1 (de) Behandlung des atemunwohlseinsyndroms bei erwachsenen.
ATE130762T1 (de) Behandlung von autoimmun-erkrankungen durch orale verabreichung von autoantigenen.
DE69132688D1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
DE3482405D1 (de) Saugfaehiges wergwerferzeugnis mit vereinigten wirkstoffen zur behandlung und prophylaxe von windelausschlag und windeldermatitis.
SG17493G (en) Ozone decontamination of blood and blood products
NL970045I2 (nl) Desulfatohirudinen, werkwijze voor hun bereiding en farmaceutische middelen.
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
DE68917219D1 (de) Therapeutisches Erzeugnis zur Behandlung von Beschwerden während der oder nach den Wechseljahren.
SE9401406D0 (sv) Pharmaceutical products for curing tumourous diseases and process for preparing same
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE68910175D1 (de) Adsorbermodul sowie Adsorberapparat zur Behandlung von Vollblut.
NO901141L (no) Additiv og fremgangsmaate for behandling av underjordiske formasjoner.
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
DE3878313D1 (de) Taurohyodeoxycholsaeure zur behandlung von gallenwegssteinen und gallenstoerungen.
ES8607916A1 (es) Un procedimiento para la preparacion de medicamentos influenciadores de la circulacion sanguinea, que contienen compuestos de bis (carboxamida)
NO890046L (no) Disubstituerte pyridiner.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE124258T1 (de) Schilddrüsenhormone zur kardialen behandlung.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
ATE187332T1 (de) Verfahren zur behandlung des symptomenkomplexes des prämenstruellen syndroms mit vitamin d oder vitamin d und calcium
ATE115863T1 (de) Verwendung eines immunglobulinhaltigen präparates zur prophylaxe und therapie von aids beim menschen.
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
ATE122100T1 (de) Humaner monoklonaler antikörper und diesen enthaltende arzneimittelzusammensetzung zur behandlung von pseudomonasinfektionen.
ATE87482T1 (de) Pharmazeutische praeparate zur behandlung von zereberalen psycho-organischen syndromen.
SU127202A1 (ru) Способ лечени л мблиоза людей

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties